Exhibit B

(Redacted)

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 1 of 24 PageID #:2603
DAVID E. HARTMAN, PHD, MS (PSYCHOPHARM), ABN, ABPP-CL 

Medical and Forensic Neuropsychology 

 216 South Jefferson, Suite 302 

 Chicago, Illinois 60661

emails: 

PHONE: Cell: 

 

NAME: 

CLAIM NO: 

AGE: DATE OF BIRTH: 

GARCIA, EDUARDO

GARCIA V. WELLS FARGO

1:20-cv-02402

60; 

EDUCATION: 

DATE OF EVALUATION: 

~11 (Mexico)

May 12 2022

HOURLY FEE: 795.00/HR (EXPEDITED REVIEW, EXAMINATION, DEPOSITION AND TRIAL RATE

CREDENTIALS: I am a board certified clinical psychologist and neuropsychologist, licensed 

in the State of Illinois with a Ph.D in Psychology from the University of Illinois, three Master’s 

Degrees (MS Psychopharmacology-Alliant University, MA Psychology-University of Illinois, 

MA Psychology-Princeton University), AB-Vassar College. My internship/residency was at 

Michael Reese Hospital, Chicago Illinois. I am a Fellow of the National Academy of 

Neuropsychology. I have published and lectured in neuropsychology and psychology for 

many years and am the primary author of a new neuropsychological test: Trails X, published 

by Psychological Assessment Resources. These and other professional credentials are 

contained in my CV and will be attached to this report. I have testified as an expert on cases, 

the most recent 4 year period of which is listed in an appendix to this document 

REASON FOR REFERRAL: Mr. Garcia was referred for neuropsychological examination to 

determine current psychological and cognitive status in the context of litigation in the 

matter listed above. Information was requested on diagnosis(es), influences on 

diagnosis(es), current work or other limitations, if any, and treatment recommendations. 

These are contained in the following neuropsychological expert report for Eduardo Garcia. 

This report contains the complete set of opinions I intend to address in this matter, barring 

new information being made available for my consideration. 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 2 of 24 PageID #:2604
GARCIA, EDUARDO Page 2 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

TESTS AND PROCEDURES

Inventario Multifasico de la Personalidad -3 {Authorized Spanish Translation - Minnesota 

Multiphasic Personality Inventory-3 (MMPI-3)}, Tasa de Inventario de la Personalidad

[Personality Assessment Inventory (PAI)-Spanish Edition], Word Memory Test (WMT-Spanish) 

Wisconsin Card Sorting Test (WCST), Computerized Assessment of Response Bias (CARBSpanish language instructions), Inventario Estructurado de Simulacion de Sintomas

(Structured Inventory of Malingered Symptomatology (SIMS), Inventory of Problems-29 (IOP29-Spanish), Clinical Interview 

MEDICAL RECORD REVIEW

Records made available for review are listed as follows: 

VIRGILI 00001 - 00178.pdf

THOMAS 00001 - 00078.pdf

POTACZEK 00001 - 00113.pdf

PILLAI 00207 - 00500.pdf

LYNCH 00243 - 00372.pdf

EDUARDO'S MED RECS 00001-00853.pdf

DEPOSITIONS: Eduardo, Julia and Byron Garcia 

Approximately 1900 pages of medical records for Mr. Garcia were reviewed and include 

records from various treaters, including Drs. Lynch, Pillai, Potaczek, Thomas and Virgili. In the 

interest of brevity, information from available records is highlighted rather than 

comprehensively abstracted in this document. All available records have been reviewed prior 

to completion of this report. 

Mr. Garcia was diagnosed with severe obstructive sleep apnea after a sleep study performed 

on March 13 2009. The study found combined apnea plus hypopnea index was 45.0 events 

per hour, with lowest oxygen desaturation of 76%. Loud snoring was noted throughout. After 

several hours, Mr. Garcia was advised that he would benefit from CPAP but he was described 

as “adamantly” refusing that option. Results were read as indicating severe obstructive sleep 

apnea, slightly worse in the supine position. It was noted that that Mr. Garcia refused to wear 

CPAP and that he did not follow up with possible surgical recommendation. 

An admission at Elmhurst Memorial Healthcare ER on May 17, 2010 noted that Mr. Garcia 

had a history of chronic back pain. Psychological symptoms of anxiety and depression were 

negative. 

Mr. Garcia’s 2011 diagnoses at the Elmhurst Clinic included hypothyroidism and vitamin D 

deficiency. 

Progress notes from September 4, 2012 described no unusual anxiety or evidence of 

depression. 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 3 of 24 PageID #:2605
GARCIA, EDUARDO Page 3 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

October 26 2017 psychiatric symptom review with Dr. Virgili at Elmhurst Clinic described 

normal mood, affect, behavior and judgment. 

Mr. Garcia’s medical diagnoses as of December 7, 2017 included unilateral inguinal hernia; 

benign lipomatous neoplasm of spermatic cord; hyperopia with astigmatism and presbyopia; 

chronic midline low back pain without sciatica; dermatitis; hypothyroidism; essential 

hypertension; obesity; hyperlipidemia; GERD and sleep apnea, unspecified.

 

CLINICAL INTERVIEW 

Per agreed upon accommodations, Mr. Garcia’s clinical interview was conducted with the 

assistance of a Spanish-language medical interpreter. Mr. Garcia is a Spanish-language 

speaking male of average height and heavyset build. He arrived on time for the evaluation. 

Mr. Garcia was accompanied by his spouse, Julia, for an examination day in which both he 

and Ms. Garcia had agreed to be alternately interviewed and complete various tests or other 

procedures, as negotiated between defense counsel and their own attorney. He and Ms. 

Garcia were made aware of my status as an examiner and were aware that reports from their 

interview and test results would be made available to defense and plaintiff counsel. Mr. 

Garcia’s interview was conducted while Ms. Garcia completed questionnaires in an adjoining 

room.

When he was not being interviewed, Mr. Garcia was also provided with questionnaires and 

objective symptom endorsement tests, with tests in their authorized Spanish-language 

versions. A medical translator remained on hand for the entire day, in case he had questions 

as to the wording or vocabulary. There were no substantive difficulties voiced with any 

materials or procedures and Mr. Garcia was considered to be cooperative and to have 

provided valid examination results. 

Mr. Garcia was oriented to time, place, person and situation. Sensorium was clear. There 

were no indications of visual or auditory hallucinations, delusions, or other psychotic process. 

Range of affect during interview appeared mildly restricted but not obviously depressed or 

anxious. Mr. Garcia denied current suicidal thoughts or plans but admitted to a single, 

momentary suicidal thought about 10 years ago during the period where his home was being 

lost to auction and he considered turning his car’s steering wheel into the path of an adjoining 

truck. He did not do so, and the thought did not recur either that day or through the present, 

even during multiple, lengthy, interstate drives. Mr. Garcia denied homicidal ideation. 

Mood swings were denied. Eye contact was normal. There were no observed attentional 

difficulties while working on test materials or being interviewed. Mr. Garcia’s replies to 

questions had normal Spanish-language cadence with no unusual volume, rate, or timbre and 

no indications of pressure, aphasia or dysarthria. His replies to questions were appropriate, 

but when asked about problems he personally was experiencing, he tended to express 

concern about his wife’s health and medical condition rather than his own issues. 

Mr. Garcia interacted normally and appropriately with this examiner and did not appear 

irritable or angry. He was able to freely converse about personal history with no signs of 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 4 of 24 PageID #:2606
GARCIA, EDUARDO Page 4 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

unusual or idiosyncratic behavior. Gait was normal. Fine motor control and coordination 

appeared to be intact. Posture was normal. Grooming and hygiene were normal. 

When asked about his most salient problems at present, Mr. Garcia repeatedly indicated that 

they are mostly related to concern about his wife's health and the difficulty her health 

problems cause him when he has to repeatedly take time away from his job to drive his wife 

to various doctor appointments. He indicated that she may have such appointments 2-3 

times within the same week and that he and his daughter must interrupt their work to drive 

her back and forth. 

Mr. Garcia described his general health as good and that he is treated with thyroid medication 

and medications for blood pressure control, including Valsartan and another whose name he 

found difficult to recall. He also takes Tramadol occasionally for pain and an unspecified 

muscle relaxant, but he does not take this regularly. He suggested that he is diabetic, but has 

not yet been prescribed insulin. He has been told to walk and exercise instead. Mr. Garcia 

indicated that all medications are provided by Dr. Munoz who practices in Elmhurst, Illinois. 

Mr. Garcia described that his blood pressure has been "slightly high" of late and that Dr. 

Munoz recently increased his blood pressure medication dose. In that context, I measured 

Mr. Garcia's blood pressure with an electronic cuff and results proved to be highly elevated 

for all three readings: 3:18 PM 173/96 pulse 95, 3:25 PM 176/103 pulse 99, 3:30 PM 150/100 

pulse 98. I wrote these readings down for Mr. Garcia and informed him that they were well 

above "slightly high" and that he needed to contact his doctor. At that point, Mr. Garcia 

admitted that he probably skipped taking his medication this morning. I asked if he had his 

blood pressure pills with him and he reported that he did. The evaluation was briefly 

interrupted to allow Mr. Garcia to take the pills he had forgotten. 

Approximately two hours later, I remeasured Mr. Garcia's blood pressure. His readings were 

not as elevated but still well into the hypertensive range: 538PM 149/87 pulse 86, 543PM

148/83 pulse 87, 550PM 141/88 pulse 90. I told Mr. Garcia that he still needs to contact his 

doctor, discuss the readings we obtained (which were also written down for him) and 

determine whether he requires an appointment and/or an adjustment of his blood pressure 

medication. Mr. Garcia agreed to do this as soon as possible. 

When I asked Mr. Garcia more specifically whether he, personally, had any physical or 

emotional problems for any reason, that he might attribute to financial bank history or 

otherwise, Mr. Garcia replied that his mood felt slightly off due to the ongoing litigation over 

his bank foreclosure. He indicated that ongoing stress of litigation makes both him and his 

wife somewhat anxious. He does not know how to deal with chronic litigation-related stress 

because he has never been in a similar situation. Mr. Garcia reported it is difficult having to 

recall the foreclosure over and over again in the context of litigation demands, as he blames 

himself for what he did or did not do, a feeling made worse because he perceives that he is 

viewed as the party legally responsible for causing the bank’s foreclosure. 

Mr. Garcia indicated that it was a tremendous shock to lose his home and that at the time, it 

was very difficult for his wife and son as well. He suggests that his son became an atheist as 

a result of the foreclosure; his son had previously been a church volunteer and prayer group 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 5 of 24 PageID #:2607
GARCIA, EDUARDO Page 5 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

leader, but after the foreclosure, he told Mr. Garcia that ‘God did not exist’. 

Mr. Garcia also blames the mortgage lender for making it difficult for his family to rent an 

apartment after the foreclosure. He believes that that negative financial information was 

provided by lender in response to landlord inquiry and tainted his family's ability to find a 

new rental residence. Eventually, however, Mr. Garcia and his family were able to find an 

apartment in Cicero where they have lived for approximately 6-8 years. 

Over time, Mr. Garcia reports that he has continued to work hard and build a small business, 

creating custom wood furniture tables and chairs. He works with his son and they arrange 

their schedules to manage several employees. He does not believe he has any work-related 

impairments and feels quite happy about his work quality and productivity. He did not initially 

believe he could be as successful as he has become, and describes his work as of such high 

quality that it is known to be one of the best in Chicago. He asserts that his products have 

reached every state in the union, “even Canada and Hawaii”. He attributes his success to the 

role model of his hard-working father and that, as the oldest of 11 children, he has tried to 

follow his father’s good example. 

Mr. Garcia lives with his wife and his daughter. His wife is not currently working and his 

daughter works for the State. He is uncertain as to his daughter’s career but suggests it is 

public aid-related. His son is married. His daughter is not married and lives with Mr. Garcia 

and his spouse. Mr. Garcia indicated that he has a large, actively social family. He or his 

siblings are always having have parties. His last party was on April 15 and was quite large, 

because they have such a huge family. 

Mr. Garcia denied any ongoing medical problems. He recalls having gone to an Emergency 

Room once for a knee infection around 2006-2008. Approximately 3-4 years ago, he 

underwent a successful surgical hernia repair. He denies drinking alcohol, stating that it has 

never appealed to him. He drinks 1 cup of coffee a day and will occasionally take cold 

medicine but does not regularly take other over-the-counter vitamin supplements or 

medications. 

I asked Mr. Garcia for a third time whether he could think of any specific emotional difficulties 

that he attributes to his foreclosure. He indicated that during the height of the bank 

foreclosure, it weighed heavily on his shoulders. He recalled that about 10 years ago, while 

driving his car next to a large truck on the highway, it very briefly crossed his mind that he 

might swerve into the wheels of the truck. Mr. Garcia discarded the thought immediately, 

which did not recur, but memory of having this brief thought at all continues to disturb him. 

For many years since then he has driven back and forth to Indiana as part of his work but has 

not had a recurrence of that thought. 

I also asked Mr. Garcia about an item that he circled on a history questionnaire related to 

other legal difficulties he experienced. He reported having been fined for several expired city 

stickers on his car and that he had to pay back fees. 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 6 of 24 PageID #:2608
GARCIA, EDUARDO Page 6 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

TEST RESULTS 

Spanish language cognitive performance validity tests (WMT; CARB) were passed, with no 

attempt to exaggerate cognitive deficit. Symptom endorsement validity test results were 

more variable. Mr. Garcia produced an elevated score on the Spanish language version of 

the The Structured Inventory of Malingered Symptomatology (SIMS) a self-administered 

measure developed as a screening tool for the detection of feigned or exaggerated psychiatric 

disturbance and cognitive dysfunction. The SIMS has a 5th grade reading level to allow for 

completion by a wide range of individuals. Mr. Garcia’s Total SIMS score was above the cutoff 

for an exaggerated symptom endorsement protocol and reflected endorsement of rare, 

bizarre or implausible symptoms, especially with respect to neurologic, depression/anxiety 

(Affective), thought disorder (Psychotic) and simple, knowledge-based (Intellectual) 

questions. Results suggest the possibility of symptom magnification in these symptom areas 

(see graph following). 

Mr. Garcia’s symptom profile on a second brief inventory that is sensitive to exaggerated 

symptom admission (Inventory of Problems-29-Spanish language version) was equivocal for 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 7 of 24 PageID #:2609
GARCIA, EDUARDO Page 7 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

exaggeration. Using the expected base rate norms in forensic cases, his score would indicate 

exaggeration. In more general populations, his score (.47) is under the test cut-off for 

exaggeration. 

Mr. Garcia’s validity scales on two comprehensive symptom endorsement and personality 

inventories (PAI; MMPI-3) did not show exaggeration. 

Mr. Garcia was given a nonverbal test of problem-solving (WCST) in which he was asked to 

sort cards into categories by receiving feedback about whether each successive answer was 

correct or incorrect. He was unable to generate any consistent categorical sorting strategies. 

It is unclear whether this represents a decline or a limitation of low schooling. If Mr. Garcia is 

noted to have cognitive difficulties related to his work or general life function, consider 

neurologic referral. 

On the Spanish-language version of a word list learning and memory test, which is sensitive 

to both credible and implausible memory deficit, (WMT), Mr. Garcia showed valid effort and 

long-term memory word list recall was consistent that of individuals having less than nine 

years of education but showing good effort. 

On a comprehensive objective personality and symptom self-report inventory (PAI), Mr. 

Garcia’s PAI showed no indications of exaggeration. He described himself as being relatively 

free of common shortcomings, suggesting that he may have minimized any difficulties. 

Mr. Garcia's clinical profile on the PAI did not reveal any marked elevations on scales that 

might indicate diagnosable clinical psychopathology. He had some isolated areas of concern, 

including relatively mild or transient depressive symptomatology, disturbed sleep and 

possible decrease in energy and/or sexual interest. He described himself as being socially 

isolated with few interpersonal relationships that could be described as close to warm, 

although this appears to be contradicted by his interview statements. Mr. Garcia denied 

difficulties with antisocial behavior, paranoia mood swings, marked anxiety or health 

impairment. He denied substance abuse or dependence or dependence. Per PAI results, Mr. 

Garcia described a somewhat self-critical self-concept with a focus on past failures and he 

may be more troubled by self-doubt about his adequacy than others observe. He endorsed 

being unfeeling, punitive and unable to display affection. This also appeared to be 

contradicted by statements during interview. 

Mr. Garcia characterized availability of social support and recent level of stress on the PAI as 

about average, compared to normal adults. He is not being troubled by thoughts of self- harm 

and he described his temper as fairly well controlled without apparent difficulty. PAI results 

suggest that if psychological symptoms are of concern, appeared to best resemble a low level 

persistent depression (dysthymia). 

Mr. Garcia was also given the Spanish language version of the MMPI-3, the current version of 

most widely used symptom and personality inventory in psychology. His pattern of responses 

was valid for all MMPI-3 validity scales. There were no indications of exaggeration or 

minimization. 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 8 of 24 PageID #:2610
GARCIA, EDUARDO Page 8 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

MMI-3 “Higher Order” scales were all normal range. On scales related to somatic, cognitive 

and internalizing issues, Mr. Garcia produced an elevated MLS scale, consistent with 

experience of poor health, fatigue or sleep disturbance, low energy and/or sexual 

dysfunction. He endorsed a single question about suicide positively, consistent with his 

interview statement about a transient past thought. 

On scales related to "externalizing" and interpersonal patterns, Mr. Garcia described himself 

as being assertive, direct and being able to lead others. He also produced an elevated score 

on a scale related to social avoidance which describes someone who is introverted, has 

difficulty forming close relationships, and who may be emotionally restricted and 

embarrassed and/or uncomfortable around others. The MMPI-3 also has several scales 

related to general personality and temperament (PSY-5). Mr. Garcia endorsed high levels of 

pessimism, introversion, lack of positive emotional experiences and possible loss of pleasure 

in previously enjoyed activities. 

CONCLUSIONS

Mr. Garcia is a Spanish-speaking male who was seen as part of psychological evaluation to 

obtain current information in the context of litigation. Examination time and general 

framework were previously agreed upon by defense and plaintiff attorneys. The referral 

source who arranged for his examination in my office was Winston & Strawn, attorneys for 

Wells Fargo. Mr. Garcia and his spouse were examined without incident and both Ms. and 

Mr. Garcia expressed understanding of my role as an examiner in their case, where both 

defense and plaintiff law firms would have access to my report, based on my review and 

results from their examinations. 

Record review performed in the context of this evaluation was notable for history of 

hypertension, possible medication noncompliance and severe untreated obstructive sleep 

apnea. 

Mr. Garcia’s cognitive performance validity tests were in the normal range, indicating no 

attempt to distort neuropsychological performance. Alternately, he displayed mixed validity 

results on symptom endorsement validity scales. Two stand-alone tests for symptom validity 

(SIMS; IOP-29) suggested symptom magnification. Two comprehensive personality tests with 

validity scales (PAI; MMPI-3) did not. Results suggested some caution about uncritically 

accepting Mr. Garcia’s self-report about symptoms and their causes. 

Mr. Garcia displayed observationally normal mental status, but failed a test of non-verbal 

problem solving, which may represent a decline from long-term best cognitive performance. 

This is of concern because he has two disorders of record that are capable of producing brainbased decline in neuropsychological function: hypertension and obstructive sleep apnea. 

Hypertension can contribute to progressive cognitive impairment1 and elevates risk for stroke 

and myocardial infarction. Long-standing hypertension reduces cerebral blood flow, 

1 Birns J, Morris R, Jarosz J, Markus HS, Kalra L. (2009) Hypertension-related cognitive decline: is the 

right time for intervention studies? Minerva Cardioangiologica, 57, 813-830.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 9 of 24 PageID #:2611
GARCIA, EDUARDO Page 9 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

metabolism, and cognitive function2. Hypertension is associated with cortical atrophy in older 

adults3 and is a risk factor for cognitive decline4. Hypertension is also associated with 

depressive disorder, stress-related complaints and somatoform disorders5 and may 

contribute to any chronic low level depressive symptoms experienced by Mr. Garcia. For this 

disorder alone, Mr. Garcia requires consultation with his treating physician to prevent 

undesirable progressive neuropsychological and neurologic consequences of chronic high 

blood pressure. 

Mr. Garcia’s untreated obstructive sleep apnea (OSA) is also of neuropsychological concern 

because OSA causes or contributes to progressive white matter disease and may be a marker 

for subclinical cerebrovascular or cardiovascular disease.6 Daytime sleepiness or fatigue is a 

frequent concomitant of sleep apnea and even mild sleep apnea may worsen depression and 

the quality of life.7 Neuroanatomical regions and neuropsychological functions can be 

impaired as a consequence of sleep apnea, with memory and executive function impairment 

from hippocampal atrophy and white matter frontal lobe damage. 8

From a psychological perspective, Mr. Garcia did not show any observational indications of 

major depression or anxiety disorder. Most of the difficulties he relates are centered on 

concern for his wife’s symptoms and the difficulties he experiences arranging and driving her 

to physician visits that interrupt his workdays. Mr. Garcia reported an isolated transient 

suicidal thought while driving about 10 years ago. While having this thought continues to 

concern him, he has had no subsequent similar thoughts. He is proud of his work and reports 

2 Fujishima M., Ibayashi S., Fujii K., and Mori S. (1995). Cerebral blood flow and brain function in 

hypertension. Hypertension Research 18, 111-17.

3 Heijer T, Skoog I, Oudkerk M, de Leeuw FE, de Groot JC, Hofman A, Breteler MM. (2003). Association 

between blood pressure levels over time and brain atrophy in the elderly. Neurobiology of 

Aging. 24, 307-313.

4 Meyer JS, Rauch G, Rauch RA, Haque A. (2000). Risk factors for cerebral hypoperfusion, mild 

cognitive impairment, and dementia. Neurobiology of Aging. 21, 161-169.

5 Cha, S., and Kim, S-S. (2021). Comorbidity patterns of mood disorders in adults inpatients: Applying 

Association rule mining. Healthcare, 9, 1-16.

6 Robbins, J., Redline, S., Ervin, A., Waisieben, J. A., Ding, J., and Nieto, F. J. (2005). Associations of 

sleep-disordered breathing and cerebral changes on MRI. Journal of Clinical Sleep Medicine, 

April 15, 1, 159-165.

7 Brown, W. D. (2005). The psychosocial aspects of obstructive sleep apnea. Seminars in respiratory 

critical care medicine, 26, 33-43.

8

 Zimmerman ME, Aloia M. S. (2006). A review of neuroimaging in obstructive sleep apnea. Journal 

of Clinical Sleep Medicine, Oct 15;2, 461-471.

 

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 10 of 24 PageID #:2612
GARCIA, EDUARDO Page 10 of 10

Psychological Evaluation David E. Hartman PhD MS ABN ABPP

building a career as a successful and respected craftsman. He reports having a very large and 

social family. 

Objective personality inventory results suggest the possibility of chronic low-level depressive 

symptoms, the etiology of which is unclear considering the likely influence of chronic and 

progressive medical disorders described above. Mr. Garcia's description of having frequent 

parties in a very large family is inconsistent with his self-portrayal on tests as being isolated 

and anhedonic. 

There were no indications of a diagnosable stress disorder specific to bank and mortgage 

difficulties. While Mr. Garcia described this event as understandably shocking and stressful, 

he does not describe a diagnosable constellation of symptoms at that time and does not 

describe any continuing emotional or behavioral condition stemming from this incident other 

than the ongoing stress of litigation and a sense of guilt and responsibility he feels for losing 

the family home. 

Diagnostically, Mr. Garcia's objective test results are consistent with (ICD-10) F34.1 Dysthymic 

disorder, connoting chronic, nonspecific low-level depression. There is a rule out diagnosis of 

F06.31 Mood Disorder Due to Known Physiological Condition, connoting the influences of 

chronic hypertension and obstructive sleep apnea on mood. There is also a rule out of F06.8 

Mental Disorder Due to Known Medical Condition, connoting possible mild cognitive decline 

from progressive consequences of hypertension and obstructive sleep apnea. Consider 

referral for neurologic workup if behavioral or cognitive inefficiencies are noted at work or at 

home.

 

Based on current blood pressure readings, Mr. Garcia requires aggressive blood pressure 

management. Treatment compliance may be an issue as he reports having forgotten to take 

blood pressure medication on the day of this evaluation and he was previously noncompliant 

with clinical recommendation for CPAP. He may benefit from discussion with a trusted 

physician about the consequences of hypertension and untreated obstructive sleep apnea. 

He is at risk for neuropsychological and psychological deterioration as a function of 

hypertension and obstructive sleep apnea. 

Unless otherwise stated, all opinions in this report are made to a reasonable standard of 

neuropsychological and psychological certainty. I reserve the right to extend and/or amend 

current opinions if additional information is presented for my review. Thank you for the 

opportunity to provide consultation on this very interesting case. 

David E Hartman, Ph.D., MS (Psychopharmacology) ABN, ABPP-Cl

Clinical Neuropsychologist 

IL license: 071-003149

Diplomate: American Board of Professional Neuropsychology 

Diplomate: American Board of Professional Psychology-Clinical

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 11 of 24 PageID #:2613
Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 12 of 24 PageID #:2614
CV3⁄4Dr. David Hartman Page 2 of 12

TEACHING EXPERIENCE (cont.):

1979-81 Medical Psychotherapist: Department of Transplantation Surgery, University of Illinois 

Medical Center, Chicago, Illinois.

1993-2000 Instructor in psychological testing methods and psychotherapy to Rush Presbyterian St.

Luke’s Hospital psychiatry residents.

1990-1995 Adjunct Associate Professor of Psychiatry and Behavioral Sciences, Chicago Medical 

School. Teaching and supervision of psychiatryresidents.

1987-92 Neuropsychology Internship Seminar. Teaching and supervision of psychology interns.

Illinois State Psychiatric Institute (ISPI).

1987 Graduate Seminar in Clinical Neuropsychology. Department of Psychology, Illinois Institute

of Technology (IIT).

1985-86 Clinical Practice and Theories of Psychoanalytic Psychotherapy. Full year graduate level 

course for the Columbus Hospital, Lincoln Park Clinic Externship Program in Clinical 

Psychology and Social Work. Chicago,Illinois.

1984-92 Adjunct Assistant Professor of Psychology, Department of Psychiatry, University of Illinois 

College of Medicine at Chicago. Chicago,Illinois.

1983-92 Theory and Practice of Clinical Neuropsychology, Graduate course for psychology interns

and invited participants. Cook CountyHospital.

1982-92 Brief seminars: taught at Cook County Hospital for the psychology internship program, 

including introductions to: Self Psychology, Hypnosis, Rorschach Exner System & Stress 

Management.

FORENSIC EXPERIENCE:

Expert witness: Clinical, Forensic and Medical Neuropsychology; Civil and Criminal Consultation;

behavioral toxicology; Clinicalpsychology.

1992-2010 Consultant; Cavanaugh & Associates, Neuropsychologicaland general

psychological consultant in civil forensic psychological cases.

TESTS: Hartman, D. E., and Reynolds, C. (May 2019) TRAILS-X, Boca Raton, Fl. Psychological

Assessment Resources.

PUBLICATIONS: (BOOKS)

Hartman, D. E. (1995). Neuropsychological Toxicology: Identification and Assessment of Human Neurotoxic 

Syndromes 2nd Edition. New York: Springer Publications. (First edition published by Pergamon Press 

in 1988).

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 13 of 24 PageID #:2615
CV3⁄4Dr. David Hartman Page 3 of 12

BOOK CHAPTERS:

Hartman, D. E. (2018). Early evolution and forgotten founders of clinical neuropsychology. In, W. Barr (Ed.)

Oxford Handbook on the History of Neuropsychology. 

Hartman, D. E. (2018). Evolution, forensic implications and future of somatic symptom disorders. In S. Bush,

G. Demakis & M. Rohling (Eds.). Handbook of Forensic Neuropsychology.

Hartman, D. E. (2018). Differential Diagnosis in Neuropsychology: A Strategic Approach. In J. Morgan & J. 

Ricker (Eds.) Textbook of Clinical Neuropsychology, 2nd Edition.

Hartman, D. E. (2000). Neuropsychology and the (Neuro) Toxic Tort. In J. Sweet (Ed.), Forensic 

Neuropsychology: Fundamentals and Practice. Swets.

Hartman, D. E. (1998). Missed Diagnoses and Misdiagnoses of Environmental Toxicant Exposure: The 

Psychiatry of Toxic Exposure and Multiple Chemical Sensitivity. Psychiatric Clinics of North America, 

21, 659-669

Hartman, D. E. (1998). Inhalants: Behavioral Pharmacology. In R. E. Tarter, R. A. Ammerman & P. J. Ott (Eds.)

Handbook of Substance Abuse: Neurobehavioral Pharmacology, Plenum Press.

Hartman, D. E. (1996). Ecological validity and the evolution of clinical neuropsychology. In. R. Sbordone (Ed.),

Ecological Validity and Clinical Neuropsychology. St. Lucie Press.

Hartman, D. E., and Hessl, S., and Tarcher, A. (1992). Neurobehavioral evaluation of environmental toxin 

exposure: Rationale and Review. In A. Tarcher (Ed.). Principles and Practice of Environmental 

Medicine. Plenum Press.

Hartman, D. E. (1992). Neuropsychological toxicology. In A. Puente and B. McCaffrey (Eds.) Handbook of 

Neuropsychological Assessment, Plenum Press, 485-507.

Hartman, D. E. and Kleinmuntz, B. (1991). Computers in psychological practice: Historical and current uses. 

In J. Sweet, R. Rozensky and Tovian (Eds.). Handbook of Clinical Psychology in Medical Settings. 

Plenum Press.

Hartman, D. E. (1990). The computerized clinician: Ethical, legal and professional issues in the use of 

psychologicalsoftware. In E. Margenau (Ed.). The Encyclopedic Handbook of Private Practice. Gardner 

Press.

ARTICLES:

Flaro, L., Gervais, R., Hartman, D. E. and Rohling, M. (in press). Paul Green (1951-2020): A tribute.

Developmental Neuropsychology.

Hartman, D. E. (2010). “I am the very model of a modern expert witness.” Book Review: Forensic 

Neuropsychology Casebook, R. Heilbronner (Ed.). Journal of Clinical and Experimental 

Neuropsychology, 32, 445-447.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 14 of 24 PageID #:2616
CV3⁄4Dr. David Hartman Page 4 of 12

ARTICLES (cont.):

Hartman, D. E. (2009). Test Review: Wechsler Adult Intelligence Scale IV: Return of the Gold Standard.

Applied Neuropsychology, 16, 85-87

Hartman, D. E. (2008). Test Review: The Computerized Test of Information Processing (CTIP) by Tom 

Tombaugh, 15, 226-227.

Hartman, D. E. (2008). Test Review: The Iowa Gambling Task: Not just another 12 step program. Applied 

Neuropsychology, 15, 158-159.

Hartman, D. E. (2008). Test Review: Test Sematary: Koppitz-2 Developmental Scoring System for the Bender 

Gestalt Test, Applied Neuropsychology, 15, 94 - 95

Hartman, D. E. (2007). Test Review: The Test of Memory and Learning -2, Applied Neuropsychology, 14, 3-7- 

309.

Hartman, D. E. (2007) Test Review: The Wide Range Assessment of Memory and Learning (WRAML-2),

Applied Neuropsychology, 14, 138-140.

Hartman, D. E. (2006). “The Weight is Over.” Test Review: The Neuropsychological Assessment Battery 

(NAB). Applied Neuropsychology, 13, 58-61.

Hartman, D. E. (2006). “And now for something (almost) completely different”: Book Review: Forensic 

Neuropsychology: A Scientific Approach by Glenn J. Larrabee (Ed.). (Book Review). Applied 

Neuropsychology.

Hartman, D. E. (2002). “The unexamined lie is a lie worth fibbing”: Neuropsychological malingering and the 

Word Memory Test. Archives of Clinical Neuropsychology, 17, 709-714

Hartman, D. E. (April 20, 2001). On Beyond Arsenic: Child Neurotoxic Exposure. Mealey’s Emerging Toxic 

Torts, King of Prussia, PA

Ruffalo, CA, Gouvier, WD, Pinkston, JB, Tucker, KA, Hartman, DE, Dahlgren, JG, & Parker, FM (in press). 

Ethylene dichloride: Neuropsychological effects of chronic exposure. (abstract). Archives of Clinical 

Neuropsychology. 

Hartman, D. E. (May 5 2000). Poisoned Minds: Understanding and evaluating neurotoxic brain damage 

claims. . Mealey’s Emerging Toxic Torts, King of Prussia, PA

Reissman, D. B., Orris, P., Lacey, R. and Hartman, D. E. (1999). Downsizing, Role Demands and Job Stress.

Journal of Occupational and Environmental Medicine. 41(4):289-293.

Caruso, L. S. and Hartman, D. E. (Book Review, 1999). Detection of malingering during head injury Litigation.

C.E. Reynolds, (Ed.). Plenum Press. Journal of Forensic Neuropsychology, 1, 59-66.

Caruso, L. S. and Hartman, D. E. (Book Review, 1998). The practice of forensic neuropsychology. R. J. 

McCaffrey, A. D. Williams, J. M. Fisher, and L. C. Laing (Eds.), Archives of Clinical Neuropsychology

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 15 of 24 PageID #:2617
CV3⁄4Dr. David Hartman Page 5 of 12

ARTICLES (cont.):

Haywood, T. W., Hartman, D. E., Fletcher, T. A., & Kravitz, H.M. (1997). Response bias and cognitive 

performance in alleged impaired professionals (abstract). The Clinical Neuropsychologist, 12, 272.

Orris, P., Hartman, D. E., Strauss, P., Anderson, R. J., Collins, J., Knopp, C., Xu, X., and Melius, J. (1997). Stress 

Among Package Truck Drivers. American Journal of Industrial Medicine, 31, 202-210.

Laatsch, L., Hartman, D. E., and Stone, J. L. (1994). Neuropsychological evidence of amnesia following excision 

of an intraventricular tumor using a transcallosal approach: Interaction with alcohol abuse. Journal 

of Neurology, Neurosurgery andPsychiatry

Hartman, D. E. (1992). (Book Review) Residual Effects of Abused Drugs: NIDA Research Monograph 101,

Archives of Clinical Neuropsychology, 7, 467-470.

Hartman, D. E. (1991). Reply to Reitan: Unexamined premises and the evolution of clinical neuropsychology.

Archives of Clinical Neuropsychology. 6, 147-166

Hartman, D. E. (1988). Neuropsychology and the neurochemical lesion: Evolution, applications and 

extensions. NeuroToxicology. 9, 401-404.

Hartman, D. E. (1988). Book Review: Medical Neuropsychology: The Impact of Disease on Behavior., R. E. 

Tarter, D. H. Van Thiel & K. L. Edwards (Eds.). Archives of Clinical Neuropsychology, 3, 299-301.

Hartman, D. E. (1987). Neuropsychological Toxicology: Identification and assessment of neurotoxic 

syndromes. Archives of Clinical Neuropsychology, 2, 45-65.

Hartman, D. E., and Powsner, S. M., (1987). Identification with a brain-damaged parent: Theoretical 

considerations on a case of self-mutilation. Psychoanalytic Psychology, 4, 171-178.

Hartman, D. E. (1986). Artificial intelligence or artificial psychologist?: Conceptual issues in clinical 

microcomputer use. Professional Psychology: Research and Practice, 17, 528-534.

Hartman, D. E. (1986). On the use of clinical psychology software: Practical, legal and ethical concerns.

Professional Psychology: Research and Practice, 17, 462-465.

Hartman, D. E. (1986). Book Review: Understanding Brain Damage, by K. Walsh, Archives of Clinical 

Neuropsychology, 1, 31-33.

Hartman, D. E., Sweet, J. & Elvart, A. (1985). Neuropsychological effects of Wernicke's encephalopathy as a 

consequence of hyperemesis gravidarum: A case study. International Journal of Clinical 

Neuropsychology, 7, 204-207.

Strauss, B., Hartman, D. E., and Soper, H. (1985). Cautions in alternate form presentation of aural test 

material: Speech sounds perception test. Perceptual and Motor Skills, 61, 899-902.

Hartman, D. E. and Bonecutter B. E. “Mixed Blessing.” [letter to the editor] APA Monitor, August, 1984.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 16 of 24 PageID #:2618
CV3⁄4Dr. David Hartman Page 6 of 12

PAPERS & PRESENTATIONS:

Green, J., Messer, M., Hartman, D. E., and Reynolds, C. (2019). Trails-X Trail-level performance using 

the Profile Variability Index. Poster Presentation: National Academy of Neuropsychology, 

Annual Conference, November 13-16.

Green, J., Messer, M., Hartman, D. E. and Reynolds, C. (2019). The Trails-X: Development and validation of 

a novel trail-making test. Presented at the April 12-14 2019 Poster session of the American Academy 

of Pediatric Neuropsychology (AAPdN), Las VegasNV.

Hartman, D. (2013). Low Level Lead Poisoning: The More We Know, the Lower We Go. Presented at the 

Annual Meeting of the American Academy of Clinical Neuropsychology, Chicago, IL, 6/20/13.

Denney, R., Hartman, D., Larrabee, G., and Boone, K. (2011). Forensic Grand Rounds. National Academy of 

Neuropsychology, Marco Island, FL. 11/17/2011

Hartman, D. E. (Chair), Rohling, M. and Spector, J. (2009). Toxicology for Neuropsychologists: Poisonous 

Principles, Morbid Methodology and Fatal Forensic Flaws. Invited panel presentation to the 2009 

annual meeting of the American Academy of Clinical Neuropsychology (AACN), Chicago, IL.

Hartman, D. E. (2009). A Very Gorey Introduction to the Principles of Toxicology. Invited presentation to the 

2009 annual meeting of the American Academy of Clinical Neuropsychology (AACN), Chicago, IL

Hartman, D. E. (2008). Arsenic to Zinc: An Alphabetical Introduction to the Principles of Toxicology. Invited 

Presentation to the British Psychological Society, London, England, November 5, 2008.

Pipkin, S. P., Denney, R. L., and Hartman, D. E. (October 25, 2008). Detecting exaggeration in neurocognitive 

dysfunction: Predicting Word memory Test and Fake Bad Scale classification with the Structured 

Inventory of Malingered Symptomatology. Presented at the National Academy of Neuropsychology, 

28th Annual Conference, New York City, New York.

Hartman, D. E. (2008). Multiple Chemical Sensitivity, Postconcussion Syndrome and Bleeding Edge Disorders.

Invited presentation to the British Psychological Society, London, England, November 5 2008.

Hartman, D. E. (2008). Post Traumatic Stress Disorder. Chicago Bar Association Invited Presentation, May 

30, 2008, Chicago, Illinois.

Hartman, D. E. (2007). Traumatic Brain Injury: Epidemiology, Return to Work and Distinguishing Disability 

from Dissimulation. Invited presentation to the Fifth Annual Mid-Atlantic Regional Conference on 

Occupational Medicine (MARCOM), sponsored by the Maryland College of Occupational and 

Environmental Medicine and the Philadelphia Occupational and Environmental Medicine Society, 

with support from the Johns Hopkins/NIOSH Education and Research Center. Saturday, October 13, 

2007, Johns Hopkins School of Nursing.

Hartman, D. E., (Chair and Panel Member) Ewbank, J., Courtney, J., Forest, B. & Reynolds, C. (October 26, 

2006). “War of the Words: Surviving the Neuropsychological Deposition. Presented at the Annual 

Meeting of the National Academy of Neuropsychology, San Antonio Texas.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 17 of 24 PageID #:2619
CV3⁄4Dr. David Hartman Page 7 of 12

Hartman, D. E. (May 21, 2007): Introduction to objective assessment of symptom self-report and cognitive 

malingering assessment. Presented at the Annual Meeting of the American Psychiatric Association, 

San Diego, California.

Hartman, D. E. (May 25, 2006). Advances in the Evaluation of Neuropsychological Malingering. Presented 

at the Annual Meeting of the American Psychiatric Association, Toronto, Canada.

Hartman, D. E. (May 26, 2005). Basic principles and evaluation strategies to detect cognitive malingering. 

Presented at the annual meeting of the American Psychiatric Association, World Conference Center, 

Atlanta Georgia.

Hartman, D. E. (March 14 2005). Recommendations and Critique of Welding Rod Manganese Neurotoxicity 

Research. Invited lecture presented at the second Mealey’s Welding Rod Litigation Conference, 

Phoenix Arizona, Ritz Carlton Hotel.

Hartman, D. E. (October 7 2004). The Rules: Interpreting Forensic Neuropsychological Research. Invited 

lecture presented at the Mealey’s Welding Rod Litigation Conference, Palm Springs, Florida, Four 

Seasons Hotel.

Hartman, D. E. (May 6, 2004). Neuropsychological Malingering. Invited lecture presented to the Annual 

Meeting of the American Psychiatric Association, Jacob Javits Center, New York City, New York.

Hartman, D. E. (April 28 2004). Medical Mysteries: Understanding Multiple Chemical Sensitivity as a template 

for evaluating science and clinical diagnosis in subjective medical disorders. Presented at the PDC 

Disability Experts Forum, San Destin,Florida.

Hartman, D. E. (Saturday September 6, 2003) Cause and Defect: Clinical versus Laboratory Causation in 

Neurotoxic Exposure. Invited address to NAACT: North American Congress of Clinical Toxicology, 

Chicago, Illinois.

Hartman, D. E. (May 9 2001). Understanding and detecting cognitive malingering. Invited presentation to 

the annual meeting of the American Psychiatric Association, New Orleans, LA.

Hartman, D. E. (Nov 2000) Pediatric Neuropsychological Toxicology. Invited 3 hour teaching seminar to the 

2000 Meeting of the National Academy of Neuropsychology, Orlando, Florida

Hartman, D. E. (May 30 2000) Neuropsychological Evaluation of Traumatic Brain Injury. Presented to the 

CONCENTRA Organization, Rosemont, Illinois.

Hartman, D. E. (May 15 2000). Detection of Neuropsychological Malingering. Presented at the annual 

meeting of the American Psychiatric Association, Chicago, Illinois

Hartman, D. E. (2000) Pediatric and Developmental Neuropsychological Toxicology. Presented at the World 

Conference of Pediatric Neuropsychology. Fielding Institute and The Menninger Clinic, Saturday, 

January 21, 2000. Santa Barbara, California

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 18 of 24 PageID #:2620
CV3⁄4Dr. David Hartman Page 8 of 12

PAPERS & PRESENTATIONS:

Hartman, D. E., Haywood, T. W., Sivan, A. B., and Kravitz, H. M. Sensitivity of Microcog in assessing cognitive 

impairment among impaired professionals. Presented at the 107th annual meeting of the American 

Psychological Association, Boston, Massachusetts, August 23rd, 1999.

Hartman, D. E. (1999) Neuropsychological evaluation and prediction of traumatic brain injury sequelae.

Invited Presentation to Medical Evaluation Systems, Schaumburg, Illinois, May 11, 1999.

Fletcher, T., Hartman, D. E., and Cavanaugh, J. Fitness for duty: A multi-modal approach. Presented at the 

1998 meeting of the American Academy of Psychiatry and Law (AAPL), 10/24/98, New Orleans, LA.

Haywood, T. W., Hartman, D. E., Fletcher, T. A., and Kravitz, H. Response bias and cognitive performance in 

alleged impaired professionals. Presented at the August 1998 annual meeting of the American 

Psychological Association, San Francisco, CA.

Fletcher, T. A., Hartman, D. E., Haywood, T. W., & Cavanaugh, J. L. Fitness for duty: A multi-modal approach. 

Presented at the 1998 Annual Meeting of the American Academy of Psychiatry and the Law, New 

Orleans, LA October 24, 1998.

Hartman, D. E. The use of neuropsychological methods in fitness for duty examinations. Presented at the 

1997 meeting of the American Academy of Psychiatry and Law (AAPL), November 1997, Denver CO

Hartman, D. E. Differential Diagnosis of a New Yorker. Multi-disciplinary grand rounds case conference.

Rush Presbyterian St. Luke’s Medical Center, Chicago, Illinois, September 17, 1997.

Hartman, D. E. Neuropsychological Evaluations in Workplace Violence Assessment: Paper presented in the 

symposium “Violence in the Workplace: New Challenges,” (J. L. Cavanaugh, Chairman), at the 

American Psychiatric Association 48th Institute on Psychiatric Services, October 22, 1996.

Hartman, D. E. They Say They Can Work But What Will Happen If I Send Them Back?: Neuropsychological 

Evaluation of Fitness for Duty in Professionals. Paper presented to the 1996 National Peer Assistance 

Network for Nurses (PANN) Conference, Arlington Heights, Illinois, March 22, 1996.

Hartman, D. E. The Neuropsychology of Childhood Lead Exposure. Invited teaching seminar to the 

Department of Psychology, Children’s Memorial Hospital, March 8, 1996, Chicago, Illinois

Hunter, S. J., Sivan, A. B., Hartman, D. E., Kravitz, H., & Cavanaugh, J. (1996). When low average means 

impaired: Evaluating the neuropsychological status of professionals. Presented to the International 

Neuropsychological Society, Chicago, IL. February, 1996.

Hartman, D. E., Multiple Chemical Sensitivity: Symptoms in Search of a Science. Invited presentation to the 

Board of Directors: Workers’ Compensation Board, Halifax, Nova Scotia, December 6, 1995.

Hartman, D. E., Neuropsychological Toxicology 1995: Review and Development. Three hour teaching 

workshop presented at the 15th Annual Conference of the National Academy of Neuropsychology, 

November 2, 1995.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 19 of 24 PageID #:2621
CV3⁄4Dr. David Hartman Page 9 of 12

PAPERS & PRESENTATIONS:

Hartman, David E., Hunter, Scott J., Sivan, A. B., Kravitz, H. M. and Cavanaugh, J.C. Neuropsychologic test 

sensitivity in professionals. Paper presented to the American Academy of Psychiatry and the Law, 

Seattle Washington, October 19, 1995.

Hartman, D. E. Neurotoxic Disorders and the Neuropsychology of Abused Drugs (co-presented with T. 

Strickland, Ph.D.) Invited program presented to the National Academy of Neuropsychology, 14th 

Annual Conference, November 3, 1994, Orlando, Florida.

Hartman, D. E. Neurobiology and Neuropsychology of Drugs of Abuse: Implications for Assessment and 

Treatment (co-presented with T. Strickland, Ph.D.). Invited program presented to the National 

Academy of Neuropsychology 13th Annual Conference, October 29, 1993, Phoenix, Arizona.

Hartman, D. E. Neuropsychological Toxicology, 1994. Invited address to the annual meeting of the Colorado 

Neuropsychological Society, Boulder Colorado, October 8, 1993.

Hartman, D. E. Differential diagnosis of neurotoxic disorders, multiple chemical sensitivity and sick building 

syndrome. Presented at the annual meeting of the American Congress of Allergy and Immunology, 

Chicago, Illinois, November 13, 1992.

Strickland, A., Hartman, D. E., and Satz, P. (1991). Neuropsychological consequences of crack cocaine abuse.

Presented at the 11th annual meeting of the National Academy of Neuropsychology, Dallas, Texas.

Hartman, D. E. Introduction to the Neuropsychological Evaluation of Neurotoxic Disorders. University of 

Chicago Hospitals, Department of Psychiatry, Clinical Neurosciences Series, January, 11, 1991

Hartman, D. E. Cognitive and Behavioral Effects of Neurotoxins on Brain Status and Methods of 

Neuropsychological Assessment. Presented at the 1990 Annual Meeting of the American Bar 

Association, Section of Science and Technology, Session on Brain Damage Claims, August 5, 1990, 

Chicago, Illinois.

Hartman, D. E. Private Practice in Neuropsychological Toxicology. Presented at the July 1990 Meeting of the 

American Psychological Association: Boston, Mass.

Hartman, D. E. Overview of Current Research of Neurotoxic Effects of Industrial Chemicals. Presented at the 

1989 Cuban-United States Colloquium on Occupational Disease — Neurotoxicity of Industrial 

Chemicals, November 13, 1989, Havana, Cuba.

Hartman, D. E. Differential Diagnosis of Functional versus Neurotoxic Disorder using Neuropsychiatric 

Methods. Presented at the 1989 Cuban-United States Colloquium on Occupational 

Disease - Neurotoxicity of Industrial Chemicals, Nov. 13, 1989, Havana, Cuba.

Hartman, D. E. Chronic neuropsychological effects of industrial chemicals and abused drugs. Presented at 

the third annual Topics in Emergency Medicine: Toxicology, MESA Education and Research 

Foundation. 10/29/88, Chicago, Illinois

Hartman, D. E. Neuropsychological Toxicology. Presented at the 7th Annual meeting of the National 

Academy of Neuropsychologists (NAN), October 28, 1987.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 20 of 24 PageID #:2622
CV3⁄4Dr. David Hartman Page 10 of 12

PAPERS & PRESENTATIONS:

Hartman, D. E. Neuropsychological effects of neurotoxic substances. Presented at the 5th Anniversary 

International Neurotoxicology Conference, October, 2, 1987, Little Rock, Arkansas.

Hartman, D. E. Neuropsychological toxicology: Identification and neurobehavioral testing ofsolvent-exposed 

workers. Presented at the Midwest Regional Meeting of the American Public Health Association 

Occupational Health Section, June 6,1987.

Hartman, D. E. Absolutely essential aspects of computerizing psychological service: Ethics, Legality & 

Practicality. Presented at the 1986 annual meeting of the Illinois Psychological Association, November 

14, Chicago, Illinois.

Hartman, D. E. Neuropsychological toxicology: Neurobehavioral effects of toxic substances. Paper presented 

at the 1986 annual meeting of the Illinois Psychological Association, November 15, Chicago, Illinois.

Hartman, D. E. Neuropsychological toxicology: Effects of metals, solvents, pesticides and other nervous 

system poisons. Presented at the 10/27/86 annual meeting of the National Academy of 

Neuropsychology (NAN) Las Vegas, Nevada.

Sweet, J. & Hartman, D. E. Neuropsychological manifestations of Acquired Immunodeficiency Syndrome 

(AIDS): A case study. Presented at the 1986 annual meeting of NAN. October 27-29, Las Vegas, 

Nevada.

Hartman, D. Neuropsychological toxicology: The effects of industrial substances on brain and behavior. 

Presented at the 1986 annual meeting of the Chicago Area Council on Occupational Safety and Health 

(CACOSH) 10/11/86

Hartman, D. Neurotoxic effects of job chemicals. Paper presented at the Chicago Area Council of 

Occupational Safety and Health, (CACOSH) 3/27/85

Hartman, D., Sweet, J. & Elvart, A. A case study of the neuropsychological effects of Wernicke's 

encephalopathy induced by hyperemesis gravidarum. Presented at the 1984 annual meeting of the 

National Academy of Neuropsychologists, October 24-26, San Diego, CA.

Hartman, D. E. Neuropsychological effects of neurotoxic substances. Presented at the Midwestern 

Neuropsychology Group, Chicago, Illinois, 1984.

Hartman, D. E., & McKirnan, D. Risky decision in depression: Sad schemas produce unexpected utility values.

Presented at the 1983 annual meeting of the American Psychological Association Anaheim, CA.

Hartman, D. E. and Malecki, M. Psychological aspects of renal transplantation (video seminar). Dep’t. of 

Transplantation Surgery, University of Illinois Medical Center, Chicago, Illinois, 1981.

Glucksberg, S., Hartman, D. and Stack, R. Metaphoric comprehension is an automatic and parallel process.

Presented at the Psychonomic Society, 1977

Hartman, D. E. Effects of semantic constraint on processing ambiguous words. Presented at the 1976 annual 

meeting of the American Psychological Association, Washington, D.C.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 21 of 24 PageID #:2623
CV3⁄4Dr. David Hartman Page 12 of 12

PAST AND CURRENT MEMBERSHIPS: National Academy of Neuropsychology (NAN), International Neuropsychology 

Society (INS), Psychoanalytic Study Group, Michael Basch, M.D. (1988-1989), Self Psychology Study Group, 

Ernest Wolf, M.D. and Marian Tolpin, M.D. (1990-1998)

HONORS:

Chair: Information Technology (IT) National Academy of Neuropsychology 2006-2007 Associate Journal 

Editor: Test Reviews Journal of Applied Neuropsychology, 2006-2010 Who’s Who in Medicine and Health Care 

1st & 2nd Editions; Who’s Who in America; Who's Who in the World; Who’s Who in Science and Engineering; 

Who's Who in the Midwest, Who's Who Among Human Service Professionals Grant Proposal National 

Institute on Drug Abuse (NIDA). Reviewer:Proposal N43DA-7-6502 Computerized Neuropsychological Testing

Software Examiner: American Board of Professional Neuropsychology (ABPN) Fellow: American College of 

Professional Neuropsychology(ACPN), 1995 Fellow: National Academy of Neuropsychology (NAN),1990.

HONORS (Editorial Board): Applied Neuropsychology, 2016-; Journal of Forensic Neuropsychology, 1997-2007; 

The Professional Neuropsychologist, 1997-2007 Neuropsychology Review 1996-2007 Archives of Clinical 

Neuropsychology, 1987-1990; 1998-2008

CHAIRPERSON: 

Toxicology Presentations: 1998 Annual Meeting of the International Neuropsychological Society (INS),

Oahu, Hawaii.

Workplace Violence: Program presented at the annual meeting of the Illinois Psychological Association, 

November 9 1995. Illinois Psychological Association-Clinical Division, 1986-87.

Psychoanalysis in Chicago: New Training Opportunities. Program presented at the 1986 annual meeting of 

the Illinois Psychological Association, November 16, 1986.

Emerging Trends in Clinical Neuropsychology. Program presented at the 1986 annual meeting of the Illinois 

Psychological Association, November 15, 1986.

The Automated Psychologist: Computerizing psychological services. Program presented at the 1986 annual 

meeting of the Illinois Psychological Association, November 15, 1986.

REVIEWER: Archives of Clinical Neuropsychology, The Clinical Neuropsychologist, Neuropsychology, 

NeuroToxicology, Journal of Nervous and Mental Disease, Neuropsychology Review, Clinical Psychology in 

Medical Settings, New Scientist, Journal of Psychosomatic Research, Journal of Forensic Neuropsychology, 

Applied Neuropsychology, Journal of Clinical and Experimental Neuropsychology, Journal of Forensic 

Psychology Practice, International Journal of Occupational and Environmental Health, Child Neuropsychology

 

FACULTY: Soc. for Clin. and Exp. Hypnosis. Workshop Series, October 19-22, 1982, Indianapolis, In.

RECIPIENT: NIMH fellowship, University of Illinois, 1978-1980; Teaching fellowship and full tuition scholarship: 

Princeton University, 1975-78; Vice chair, acting chair: Princeton Graduate College, Princeton,

N.J. 1977-78; Recipient: National Science Foundation Fellowship Honorable Mention 1975; 1976; Vassar Fellowship

(Hon.), 1975; Washburn Fellowship in Psychology (Hon.), Vassar College; Phi Beta Kappa, Vassar College, 1975.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 22 of 24 PageID #:2624
DAVID E. HARTMAN, PHD, MS (PSYCHOPHARM) ABN ABPP-CL

MEDICAL AND FORENSIC NEUROPSYCHOLOGY

216 South Jefferson, Suite 302, Chicago, Illinois 60661

Office: 312-879-1111 Cell: emails:

drdavidhartman@forensicneuropsychology.co

APPENDIX II: Per request, the following represents my best effort to provide a case list where they may have

been deposition testimony or trial, for the time specified.

01/01/2018

01/03/2018

01/18/2018

02/22/2018

02/26/2018

Carlson v. Jerousek 

Hirons v. Alammrew 

Bragar v. CTA 

Carlson v. Midwest 

Chambers v. Peoples 

Gas

James Rigdon 

Gilbert Garza 

Rosalind Williams 

Williams v. Mueller 

Sarah Fowler 

Terrance Jones 

Sterba v. Summit

Motorola (class action) 

Travis Wilhite

Amanda Antonacci 

Johnson v. Gurvich 

Steven Mantzke 

Loukia Rodriguez

14 L 0264

1:16-Cv-920

2015L017

Cray Huber Horstman 

Thomas Murray Jr. Esq. 

Jade Simmons, CTA

David Farina Esq, Cray Huber

18WC7588 Derek Storm, Garofalo Schreiber & Storm

04/10/2018

06/08/2018

06/15/2018

07/20/2018

11/02/2018

11/08/2018

11/09/2018

12/21/2018

02/01/2019

04/16/2019

04/25/2019

08/08/2019

08/14/2019

17674923

20140812

15595477 DEN1L4

15 L 744

[no case # avail] 

16649548

15L3798

Tristar

Unton Inman & Fitgibbons 

Genex Services

Ron Aeschliman, Griffin Law 

Betz/Blevin Indiana

Tristar

Thomas Wolf Esq. Lewis Brisbois 

Kelly Milam, Gordon and Rees 

Michael Kokal Esq. Heyl Royster 

Marsha Gottleib AG, Carbondale 

Hebbler & Giordano, LLC.

Tristar

Valerie Peiler Esq., Brady Connolly & 

Masuda

Derek Storm, Garofalo Schreiber Storm 

Watkins & Eager

Tristar 

Gordon Rees

Joshua Rauch, Mandel Horn & Rauch

00667-P7915

16628864 DEN1W8

CDC 2017-3514

18731207

11488515-001

08/16/2019

02/26/2020

03/02/2020

03/30/2020

08/20/2020

01/06/2021

03/15/2021

03/17/2021

04/21/2021

04/24/2021

08/07/2021

09/06/2021

02/07/2022

02/17/2022

Lacretia Henderson

Barnard v. Toyota

Christopher Fritsche 

Krystal Perdue 

Rodriguez v. Simco

Rodney Molt

Chansinthanawan, K. 

Michael Silk v. Well Luck 

Doe v. Board of Ed.

Steven Winiecki 

Bates v. Matrix 

George Snure

Cotton v. Insperity

Regan v. Black

19WC26965

2016 L 001063

18705144

19L8831

45D10-1702-CT-00029

Tristar 20801212

2018 L 009973

2019 L 009496

17 L 280

2017L012666009496

17594

45D02-1710-CT-102

21WC10701

2450086

David Sethi Esq. Smith Amundsen 

Joseph Wilson Esq. Maisel & Assoc. 

Nielsen, Zehe & Antas

Kelly Milam, Gordon Rees Scully 

Williams, Porter Day & Neville 

Leahy, Eisenberg & Fraenkel

Hennessy & Roach PC

Mette, Evans & Woodside

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 23 of 24 PageID #:2625
Hartman, case list: Page 2 of 2

02/25/2022

03/30/2022

03/09/2022

Lorene Schrock 

Carlos Bowman 

Brittanie Hayes v. 

Arthur

N.Y. v. Savinovich

20d03-1903-ct-000061

3:15-cv-02315

19 L 12016

Erie Insurance

Megan Murphy, IL Atty Gen’l 

Litchfield/Cavo

04/25/2022 003951988 Eric Kleiner Esq.

Case: 1:20-cv-02402 Document #: 111-2 Filed: 06/16/22 Page 24 of 24 PageID #:2626